Valuation — not yet established
No valuation for Avail Medsystems is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($100.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Avail Medsystems
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2020 | Early Stage VC (Series B) | $100.0M | ▮ | ▮ |
| Jan 2020 | Early Stage VC | $13.7M | ▮ | ▮ |
| May 2018 | Early Stage VC | $12.9M | ▮ | ▮ |
How Avail Medsystems's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Avail Medsystems, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Avail Medsystems raised?
- Avail Medsystems has raised $100.0M in total funding across 3 recorded rounds.
- When did Avail Medsystems last raise?
- Avail Medsystems last raised in Oct 2020 (Early Stage VC (Series B)), raising $100.0M.